International Clinical Trial: Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203638) titled 'Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).

Primary Sponsor: Esraa Salah Mohamed Abdallah Eladl

Condition: Ventilator-Associated Pneumonia (VAP)

Intervention: Drug: Beta Lactam Antibiotics

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: November 1, 2024

Target Sample Size: ...